Piracetam is a nootropic drug belonging to the racetam class, first synthesized in 1964. It is a cyclic derivative of the neurotransmitter GABA and is known for its cognitive-enhancing properties. Piracetam is used in the treatment of various cognitive disorders, including dementia, vertigo, cortical myoclonus, dyslexia, and sickle cell anemia, although its efficacy for some of these conditions is debated. The drug is believed to work by modulating neuronal and vascular functions, enhancing cognitive function without acting as a sedative or stimulant. Piracetam is a positive allosteric modulator of the AMPA receptor and is thought to increase neuron excitability by acting on ion channels or ion carriers. It also improves the function of the neurotransmitter acetylcholine, which is involved in memory processes.
The above information is displayed for information purpose only, and has not been reviewed by EON nor does EON attests or validates the accuracy nor does it constitutes a recommendation or validation.
| Other Names | Nootropil |
|---|---|
| IUPAC Name | 2-(2-oxopyrrolidin-1-yl)acetamide |
| CAS | 7491-74-9 |
| Molecular Weight | 142.16 |
| Molecular Formula | C6H10N2O2 |
| SMILES | C1CC(=O)N(C1)CC(=O)N |
